Xiao Xu, PhD

AstraZeneca

Poster(s):

• B0198 - Disease Burden and Diagnosis Pathways Among Patients With EoE in the United States: Evidence From Real World Clinical Practice
  Monday, October 24, 2022

  10:00 AM – 12:00 PM ET

• B0199 - Physician-Documented Symptoms and Treatment Among Patients With Eosinophilic Esophagitis in the United States: Evidence From Real World Clinical Practice
  Monday, October 24, 2022

  10:00 AM – 12:00 PM ET

• B0200 - Characteristics of and Healthcare Cost Drivers Among U.S. Patients With Eosinophilic Esophagitis With High versus Non-High All-Cause Costs: An Analysis of Insurance Claims Data
  Monday, October 24, 2022

  10:00 AM – 12:00 PM ET